Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jason Grebely

Showing results (221-230 of 368) with videos related to

Pageof 37
Sort By:
The International Journal on Drug Policy|February 9, 2019
Safety and efficacy of glecaprevir/pibrentasvir in patients with chronic hepatitis C genotypes 1-6 receiving opioid substitution therapyJason Grebely, Gregory J Dore, Negar N Alami, et al.
Viruses|February 28, 2023
Evaluation of Simplified HCV Diagnostics in HIV/HCV Co-Infected Patients in MyanmarPhyo Pyae Nyein, Shane Tillakeratne, Sabai Phyu, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|November 11, 2023
Health-Related Quality of Life of People Who Inject Drugs: The Enhancing Treatment of Hepatitis C in Opioid Substitution Settings Engage StudyQinglu Cheng, Heather Valerio, Evan B Cunningham, et al.
Journal of Hepatology|December 15, 2010
Adherence to treatment for recently acquired hepatitis C virus (HCV) infection among injecting drug usersJason Grebely, Gail V Matthews, Margaret Hellard, et al.
The Lancet. Global Health|March 30, 2023
Global coverage of interventions to prevent and manage drug-related harms among people who inject drugs: a systematic reviewSamantha Colledge-Frisby, Sophie Ottaviano, Paige Webb, et al.
The Lancet Regional Health. Western Pacific|August 7, 2023
Optimizing point-of-care testing strategies for diagnosis and treatment of hepatitis C virus infection in Australia: a model-based cost-effectiveness analysisSophy T F Shih, Qinglu Cheng, Joanne Carson, et al.
BMC Infectious Diseases|June 2, 2016
HIV infection is associated with higher levels of monocyte chemoattractant protein-1 and eotaxin among people with recent hepatitis C virus infectionFrançois M J Lamoury, Behzad Hajarizadeh, Elizabeth Keoshkerian, et al.
The International Journal on Drug Policy|January 18, 2020
Global systematic review and ecological analysis of HIV in people who inject drugs: National population sizes and factors associated with HIV prevalenceSarah Larney, Janni Leung, Jason Grebely, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 1, 2022
Hepatitis C Virus Reinfection Following Direct-Acting Antiviral Treatment in the Prison Setting: The SToP-C StudyJoanne M Carson, Gregory J Dore, Andrew R Lloyd, et al.
Open Forum Infectious Diseases|March 31, 2025
Prevalence of Injection-Related Bacterial and Fungal Infection Among People Who Inject Drugs: A Systematic Review and Meta-analysisAlice Wheeler, Jeffrey Masters, Alyssa Pradhan, et al.
Pageof 37

Showing results (221-230 of 368) with videos related to

Sort By:
Pageof 37
The International Journal on Drug Policy|February 9, 2019
Safety and efficacy of glecaprevir/pibrentasvir in patients with chronic hepatitis C genotypes 1-6 receiving opioid substitution therapyJason Grebely, Gregory J Dore, Negar N Alami, et al.
Viruses|February 28, 2023
Evaluation of Simplified HCV Diagnostics in HIV/HCV Co-Infected Patients in MyanmarPhyo Pyae Nyein, Shane Tillakeratne, Sabai Phyu, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|November 11, 2023
Health-Related Quality of Life of People Who Inject Drugs: The Enhancing Treatment of Hepatitis C in Opioid Substitution Settings Engage StudyQinglu Cheng, Heather Valerio, Evan B Cunningham, et al.
Journal of Hepatology|December 15, 2010
Adherence to treatment for recently acquired hepatitis C virus (HCV) infection among injecting drug usersJason Grebely, Gail V Matthews, Margaret Hellard, et al.
The Lancet. Global Health|March 30, 2023
Global coverage of interventions to prevent and manage drug-related harms among people who inject drugs: a systematic reviewSamantha Colledge-Frisby, Sophie Ottaviano, Paige Webb, et al.
The Lancet Regional Health. Western Pacific|August 7, 2023
Optimizing point-of-care testing strategies for diagnosis and treatment of hepatitis C virus infection in Australia: a model-based cost-effectiveness analysisSophy T F Shih, Qinglu Cheng, Joanne Carson, et al.
BMC Infectious Diseases|June 2, 2016
HIV infection is associated with higher levels of monocyte chemoattractant protein-1 and eotaxin among people with recent hepatitis C virus infectionFrançois M J Lamoury, Behzad Hajarizadeh, Elizabeth Keoshkerian, et al.
The International Journal on Drug Policy|January 18, 2020
Global systematic review and ecological analysis of HIV in people who inject drugs: National population sizes and factors associated with HIV prevalenceSarah Larney, Janni Leung, Jason Grebely, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 1, 2022
Hepatitis C Virus Reinfection Following Direct-Acting Antiviral Treatment in the Prison Setting: The SToP-C StudyJoanne M Carson, Gregory J Dore, Andrew R Lloyd, et al.
Open Forum Infectious Diseases|March 31, 2025
Prevalence of Injection-Related Bacterial and Fungal Infection Among People Who Inject Drugs: A Systematic Review and Meta-analysisAlice Wheeler, Jeffrey Masters, Alyssa Pradhan, et al.
Pageof 37